This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
bacteria:t3e:xopj5 [2020/07/08 19:07] rkoebnik |
bacteria:t3e:xopj5 [2020/08/09 18:11] (current) rkoebnik [Biological function] |
||
---|---|---|---|
Line 20: | Line 20: | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | T3E-defective mutant was not capable of secreting | + | AvrXccB, fused to a HA tag, was shown to be secreted into culture supernatants by Western blot analysis using an anti‐haemagglutinin (HA) antibody. In contrast, a T3E-defective mutant was not capable of secreting |
=== Regulation === | === Regulation === | ||
- | The //xopE1// < | + | The //xopE1// < |
=== Phenotypes === | === Phenotypes === | ||
- | AvrXccB (XopJ5< | + | * AvrXccB (XopJ5< |
+ | * XopJ5 was found to be associated with variations in disease symptoms when testing a set of 45 //X. campestris //pv. // | ||
+ | * Experimental evidence using heterologous expression of // | ||
=== Localization === | === Localization === | ||
- | Membrane, confirmed experimentally through GFP-tagged AvrXccB expression in transgenic // | + | Plant plasma membrane, confirmed experimentally through GFP-tagged AvrXccB expression in transgenic // |
=== Enzymatic function === | === Enzymatic function === | ||
- | Cysteine protease/ | + | Cysteine protease/ |
=== Interaction partners === | === Interaction partners === | ||
- | AvrXccB interacts with SAM-MT1 in // | + | AvrXccB interacts |
===== Conservation ===== | ===== Conservation ===== | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Yes. YopJ-like effectors such as AvrBsT in //Xcv// or //Xcc//, XopJ in //Xcv//. | + | Yes. YopJ-like effectors such as AvrBsT in // |
=== In other plant pathogens/ | === In other plant pathogens/ | ||
- | Yes. YopJ-like effectors HopZ1a in //P. syringae// and Pop2 in //R. solanacearum// | + | Yes. YopJ-like effectors HopZ1a in //P. syringae// |
- | ===== References ===== | + | |
- | da Silva AC, Ferro JA, Reinach FC, Farah CS, Furlan LR, Quaggio RB, Monteiro-Vitorello CB, Van Sluys MA, Almeida NF, Alves LM, do Amaral AM, Bertolini MC, Camargo LE, Camarotte G, Cannavan F, Cardozo J, Chambergo F, Ciapina LP, Cicarelli RM, Coutinho LL, Cursino-Santos JR, El-Dorry H, Faria JB, Ferreira AJ, Ferreira RC, Ferro MI, Formighieri EF, Franco MC, Greggio CC, Gruber A, Katsuyama AM, Kishi LT, Leite RP, Lemos EG, Lemos MV, Locali EC, Machado MA, Madeira AM, Martinez-Rossi NM, Martins EC, Meidanis J, Menck CF, Miyaki CY, Moon DH, Moreira LM, Novo MT, Okura VK, Oliveira MC, Oliveira VR, Pereira HA, Rossi A, Sena JA, Silva C, de Souza RF, Spinola LA, Takita MA, Tamura RE, Teixeira EC, Tezza RI, Trindade dos Santos M, Truffi D, Tsai SM, White FF, Setubal JC, Kitajima JP (2002). Comparison of the genomes of two // | + | ===== References ===== |
- | Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification | + | da Silva AC, Ferro JA, Reinach FC, Farah CS, Furlan LR, Quaggio RB, Monteiro-Vitorello CB, Van Sluys MA, Almeida NF, Alves LM, do Amaral AM, Bertolini MC, Camargo LE, Camarotte G, Cannavan F, Cardozo |
- | Liu L, Wang Y, Cui F, Fang A, Wang S, Wang J, Wei C, Li S, Sun W (2017). The type III effector AvrXccB in // | + | Guy E, Genissel A, Hajri A, Chabannes M, David P, Carrere |
- | Rongqi X, Xianzhen L, Hongyu W, Bole J, Kai L, Yongqiang H, Jiaxuan F, Jiliang T (2006). Regulation | + | Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification |
- | Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // | + | Liu L, Wang Y, Cui F, Fang A, Wang S, Wang J, Wei C, Li S, Sun W (2017). The type III effector AvrXccB in // |
- | ===== Further reading ===== | + | Rongqi X, Xianzhen L, Hongyu W, Bole J, Kai L, Yongqiang H, Jiaxuan F, Jiliang T (2006). Regulation of eight // |
- | Guy E, Genissel A, Hajri A, Chabannes M, David P, Carrere S, Lautier M, Roux B, Boureau T, Arlat M, Poussier S, Noël LD (2013). Natural genetic variation of // | + | Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // |